Sulfacytine is a short-acting sulfonamide antibiotic. Sulfacytine is active against bacteria and is an effective agent for the research of acute uncomplicated urinary tract infections.
In Vitro
Sulfacytine is rapidly absorbed and excreted in the urine almost entirely as the unchanged active form. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Form:Solid
사양
동의어
sulfacytine | N-Sulfanilyl-1-ethylcytosine | SULFACYTINE [MART.] | Sulfacitinum | Sulfanilamide, N(1)-(1-ethyl-1,2-dihydro-2-oxo-4-pyrimidinyl)- | 4-Amino-N-(1-ethyl-2-oxo-1,2-dihydro-4-pyrimidinyl)benzenesulfonamide # | SULFACYTINE [MI] | 1-Ethyl-N-sulfanilylcytosine | N(sup1)-(1-Ethyl-1,2-dihydro-2-oxo-4-pyrimidinyl)sulfanilamide | Benz Show more
사양 및 순도
≥99%
생화학 및 생리적 메커니즘
Sulfacytine is a short-acting sulfonamide antibiotic . Sulfacytine is active against bacteria and is an effective agent for the research of acute uncomplicated urinary tract infections.
보관 조건
Store at -20°C
배송
Ice chest + Ice pads
이 제품은 콜드 체인 배송이 필요합니다.지상 및 기타 경제 서비스는 사용할 수 없습니다.
작업 유형
INHIBITOR
작동 메커니즘
Dihydropteroate synthetase inhibitor
순수함
≥99%
이름과 식별자
SMILES
CCN1C=CC(=NC1=O)NS(=O)(=O)C2=CC=C(C=C2)N
이성체 SMILES
CCN1C=CC(=NC1=O)NS(=O)(=O)C2=CC=C(C=C2)N
PubChem CID
5322
분자량
294.33
고급 데이터
작용 메커니즘
인증서(CoA, COO, BSE/TSE 및 분석 차트)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
화학 및 물리적 특성
용해성
DMSO : 125 mg/mL (424.69 mM; ultrasonic and warming and heat to 60°C)
분자량
294.33
XLogP3
0.100
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
4
Rotatable Bond Count
4
Exact Mass
294.079 Da
Monoisotopic Mass
294.079 Da
Topological Polar Surface Area
113.000 Ų
Heavy Atom Count
20
Formal Charge
0
Complexity
527.000
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
The total count of all stereochemical bonds
0
Covalently-Bonded Unit Count
1
솔루션 계산기
Molarity Calculator
Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.
Reconstitution Calculator
리뷰
고객 리뷰
Application Protocols
No manufacturer-validated protocols are provided in the Product Data for this item. The following are general, non-validated suggestions to aid method development.
Stock preparation (general):
Dissolve Sulfacytine in anhydrous DMSO to 10–100 mM. Vortex and sonicate as needed. Filter (0.22 µm) for analytical use.
Enzyme or cell-based assay setup (research only):
Prepare working dilutions in buffer (e.g., HEPES or phosphate) keeping DMSO ≤1–2% v/v. Include vehicle controls.
Incubation times and concentrations should be optimized empirically; a broad initial range (e.g., 0.1–100 µM) is common for small-molecule screening.
LC–MS quantitation (general):
Mobile phase: MeOH/H2O or ACN/H2O with 0.1% formic acid or ammonium formate. Use matrix-matched calibration and internal standards to correct ion suppression.
These are generic guidelines; adapt to Sulfacytine’s actual solubility/stability and consult primary literature for condition-specific parameters.
Biological Roles
Contextual biochemical information is provided for research planning only (no therapeutic or clinical claims).
Mechanistic class (literature/general):
Sulfonamides such as Sulfacytine are widely used as probes in studying bacterial folate biosynthesis. They mimic p-aminobenzoic acid (PABA) and competitively inhibit dihydropteroate synthase (DHPS), reducing dihydropteroate formation—an essential precursor to tetrahydrofolate.
Research utility:
Tool compound in microbiology to examine resistance determinants (e.g., DHPS mutations, efflux, plasmid-mediated resistance), synergy with folate-cycle modulators, and metabolic compensation.
Reference analyte in environmental and food safety research to trace occurrence, transformation, and removal of sulfonamide residues.
Absorption/transport (literature/general):
Aryl sulfonamides often interact with organic anion transporters and may exhibit protein binding in biological matrices—factors relevant for in vitro assay design and matrix effects in quantitative analysis.
Systems biology implications:
Perturbation of folate-dependent 1-carbon metabolism can be profiled via metabolomics readouts (e.g., changes in para-aminobenzoate, folate intermediates). Include appropriate controls to distinguish on-target from off-target effects.
For Sulfacytine-specific kinetic or binding parameters, consult primary literature and validate under your exact assay conditions.
Buffer Applications
Sulfacytine is not a buffering reagent and is not typically used to prepare biological or analytical buffers. For experimental work, select a buffer system compatible with your assay while ensuring Sulfacytine remains soluble and stable.
Practical notes (general):
Common assay buffers: phosphate, HEPES, MOPS, or Tris at pH 6.5–8.0. Verify compound stability and solubility across the chosen pH.
To enhance solubility, consider adding a small percentage of DMSO or ethanol and/or adjusting pH within the stability limits of the system.
Refer to the literature and your method development data for buffer composition tailored to Sulfacytine studies.
Green Alternatives
Green chemistry considerations focus on solvent and process choices when working with aryl sulfonamides like Sulfacytine.
Prefer ethanol/water or methanol/water systems over DMF/NMP where solubility permits. Use minimal DMSO as a cosolvent to meet target concentration, then dilute into aqueous media.
Employ mild heating (≤40 °C) and sonication rather than high-boiling toxic solvents.
Comparative view (general):
DMSO vs EtOH/H2O: DMSO has superior solvating power but higher environmental persistence; EtOH/H2O is more benign but may require pH adjustment to achieve solubility.
ACN vs MeOH in LC: MeOH is generally considered greener; adjust gradients to maintain chromatographic performance.
Waste minimization:
Prepare concentrated stocks and aliquot to reduce repeat dissolutions and waste.
Use microscale assays and 96/384-well formats to lower solvent and compound consumption.
Example decision guide (general):
Start with MeOH/H2O (or EtOH/H2O) at the required pH → if insoluble, add ≤5% DMSO → if still inadequate, move to DMSO stock followed by dilution.
Trade-offs should be documented in your method (solubility vs. assay compatibility vs. environmental impact).
Pharmaceutical Uses
No clinical or therapeutic claims are made. This section addresses research/formulation contexts only.
Research/formulation contexts (general):
May be used as a reference standard in analytical method development and validation (e.g., assay, impurities, stability-indicating methods) for sulfonamide-class compounds.
Suitable for forced degradation studies to map degradation pathways (hydrolysis, oxidation, photolysis) and build mass-balance for stability-indicating HPLC/LC–MS methods.
Applicable for excipient compatibility screens and pre-formulation experiments (pH–solubility profiling, salt screening) to understand solid-state and solution behavior.
Regulatory notes:
Unless explicitly supplied as a compendial grade, this catalog item is for research use only and not intended for human or veterinary use. Confirm regulatory status before any GMP-related activities.
Analytical controls:
Use orthogonal identity tests (MS, NMR, IR) and purity assessments (HPLC/UPLC) against the lot-specific CoA.
For pharmacopeial monograph applicability or reference standard status specific to Sulfacytine, consult current pharmacopeias and certified reference material providers.
Physical Properties
Only item-specific values provided in Product Data are listed as such; other values below are general/literature guidance for aryl sulfonamides and should not be construed as specifications for this catalog item.
Item-specific specs:
Appearance: Not specified for this item; refer to CoA/Spec Sheet.
Typical physical behavior (literature/general for aryl sulfonamides):
Physical state: usually crystalline solids with moderate to high melting points due to strong intermolecular H-bonding and dipolar SO2 interactions.
Solubility: often sparingly soluble in water at neutral pH; solubility increases in basic aqueous media (deprotonated sulfonamide) and in polar aprotic solvents (DMSO, DMF, NMP). Cosolvent systems (water/EtOH, water/propylene glycol) can improve dissolution for analytical work.
Acid–base: sulfonamide N–H typically weakly acidic (pKa commonly in the 6–11 range depending on ring substituents; literature/general). Aromatic amine/basic sites, if present, may show pKa around 1–3 (conjugate acids; literature/general).
Partitioning: logP/logD varies with substitution and ionization; neutral forms tend to be moderately lipophilic while ionized forms favor aqueous phases (literature/general).
UV: aryl sulfonamides generally exhibit UV absorption in the 250–280 nm region attributed to the aromatic ring; exact maxima are structure-dependent (literature/general).
If numeric values (mp, bp, density, refractive index, precise pKa/logP) are required, please consult the CoA/Spec Sheet or authoritative databases for Sulfacytine specifically.
Quality and Grades
Quality designation and purity are not specified in the Product Data for this item. The following notes explain typical grade terminology and considerations.
Item-specific status:
Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.
Research Use Note: For research use only.
General guidance on grades (for context):
Research/Biochemical grade: Suitable for general laboratory use; impurity limits geared to research workflows, not for human or veterinary use.
HPLC/LC–MS grade (when applicable): Emphasizes low UV background and minimal volatile/non-volatile residues for analytical applications.
USP/EP/JP compendial APIs (context only): Defined by pharmacopeial monographs; not implied for this item unless explicitly stated on the CoA/spec.
Practical implications:
Review CoA for assay, related substances, residual solvents, water content, and identity tests relevant to your application (e.g., analytical standard, biochemical assay).
If ultra-trace impurity control is critical (e.g., for LC–MS quantitation), consider pre-dissolution filtration and blank-background checks, and verify with your own method suitability tests.
For definitive grade, assay, and impurity specifications, rely on the lot-specific CoA/Spec Sheet.
Reaction and Applications
This section summarizes typical research applications for aryl sulfonamide compounds like Sulfacytine. No medical or clinical claims are made.
Biochemical research applications (literature/general):
Sulfonamides are classical inhibitors of bacterial dihydropteroate synthase (DHPS), acting as competitive analogs of p-aminobenzoic acid (PABA) in folate biosynthesis studies. Sulfacytine is used in microbiology and enzymology as a chemical probe to interrogate folate pathway flux and resistance mechanisms.
Employed in susceptibility testing panels, efflux/transporter studies, and as a reference analyte for method development (HPLC/LC–MS) in complex matrices.
Analytical applications:
Calibration standards for quantifying sulfonamides in environmental, food, or microbiological samples (with appropriate validation). Used to challenge sample preparation methods (SPE, QuEChERS) for recovery/ion suppression characterization.
Practical tips:
Prepare fresh DMSO stocks; avoid prolonged exposure to strong light/heat. Validate stability in your assay matrix (pH, ionic strength, protein content).
When studying enzyme inhibition, maintain consistent PABA levels and ionic strength; include appropriate negative controls and replicate conditions for Ki/IC50 determination (literature/general).
For specific usage parameters (concentrations, incubation times) tailor to your organism/enzyme system and consult primary literature for Sulfacytine.
Reaction Conditions
Sulfacytine is not commonly used as a reagent/solvent in synthetic reactions; however, general conditions relevant to the modification of aryl sulfonamides are provided for method-planning purposes. These are literature/general guidelines and not specifications for this item.
N-alkylation of sulfonamides (general):
Base: NaH, K2CO3, or Cs2CO3 depending on electrophile reactivity.
Solvent: DMF, DMSO, or acetonitrile; 0–60 °C; hours to overnight.
Workup: aqueous quench → extraction → silica gel purification.
N-acylation (general):
Reagents: acid chlorides or coupling agents (EDC/HOBt, HATU).
Solvent: DCM, DMF; base: DIPEA or pyridine; 0–25 °C.
Strongly deactivated by –SO2–; reactions (e.g., nitration) require controlled conditions and may give meta-directing patterns.
Stability studies (analytical context):
Hydrolysis: evaluate at pH 1–2 and pH 9–10 at elevated temperature (40–60 °C) for forced degradation profiling.
Oxidation: 0.1–3% H2O2 at room temperature for limited durations.
Photolysis: UV/visible light exposure per ICH Q1B to assess photostability.
Adapt conditions to Sulfacytine’s exact structure and verify by small-scale trials before scale-up.
Safety and Handling
Safety details specific to this item (GHS, pictograms, H-statements) are not provided in the Product Data and should be verified in the official SDS.
Item-specific safety entries:
Signal Word: Not specified for this item; refer to SDS.
H-Statements: Not specified for this item; refer to SDS.
GHS Classification: Not specified for this item; refer to SDS.
Pictograms: Not specified for this item; refer to SDS.
General handling guidance (literature/general for aryl sulfonamides):
Potential hazards: Dust may cause respiratory, eye, and skin irritation. Some sulfonamides are associated with allergenic sensitization in susceptible individuals—minimize exposure and avoid inhalation or skin contact.
PPE: Use lab coat, safety glasses, and suitable gloves (e.g., nitrile). Employ a fume hood when weighing/handling powders to control dust.
Incompatibilities: Strong oxidizers, strong bases/acids (may cause hydrolysis or degradation). Avoid prolonged exposure to light and moisture which may influence stability.
First aid overview: If inhaled, move to fresh air; if on skin, wash with soap and water; if in eyes, rinse cautiously with water; if ingested, rinse mouth. Seek medical attention per SDS directives.
Spills: Avoid dust generation; collect with inert absorbent and place in appropriate waste container. Decontaminate surfaces and dispose in accordance with local regulations.
Always consult the product-specific SDS for authoritative safety and regulatory information.
Solvent Selection
Guidance below focuses on dissolving aryl sulfonamide solids like Sulfacytine for analytical or biochemical workflows. Item-specific solubility values are not provided—verify empirically for your system.
Polarity and miscibility (literature/general):
Polar aprotic solvents (DMSO, DMF, NMP) typically afford the highest solubility for aryl sulfonamides.
Aqueous solubility tends to be limited at neutral pH but improves under mildly basic conditions (sulfonamide deprotonation) or with cosolvents (EtOH, MeOH, PEG400, propylene glycol).
Practical choices:
Stock solutions for screening: DMSO at 10–100 mM; dilute into assay buffers with final DMSO ≤1–2% v/v to minimize biological assay interference.
Preparative dissolution: Warm (≤40 °C) sonication in DMSO or DMF, followed by dilution with buffer/EtOH mixtures if required.
Analytical chemistry: For LC–MS, favor MeOH/H2O or ACN/H2O with 0.1% formic acid or ammonium formate; if insoluble, dissolve a small amount in DMSO then spike into mobile phase.
Comparison (literature/general):
DMSO: highest solvating power; potential assay interference at high %.
DMF/NMP: strong solvents; consider toxicity/handling and MS background.
EtOH/MeOH: greener, miscible; may require pH adjustment or heat to dissolve fully.
Always filter through 0.22–0.45 µm before quantitative analyses.
Storage and Reconstitution
Follow the item-specific storage guidance and general best practices for small-molecule solids and stock solutions.
Item-specific instructions (from Product Data):
Storage Conditions: Store at -20°C.
Shipped In: Ice chest + Ice pads.
General storage guidance:
Keep container tightly closed in a dry, inert atmosphere. Protect from light and moisture. Allow vials to equilibrate to room temperature in a desiccator before opening to minimize condensation.
For long-term storage, maintain at –20 °C; for frequent access, consider a desiccated 2–8 °C working stock to reduce freeze–thaw of the main lot.
Reconstitution (general suggestions):
Solvents: DMSO or DMF for concentrated stocks; for aqueous work, dilute DMSO stocks into buffer/EtOH mixtures. Verify compatibility with your assay.
Typical stock concentrations: 10–100 mM in DMSO (research use). Filter sterilize if sterility is required for cell-based assays.
Aliquoting: Dispense single-use aliquots and store at –20 °C. Avoid repeated freeze–thaw cycles.
Stability: Assess solution stability by LC–UV/LC–MS over intended use intervals; discard if precipitation, discoloration, or degradation is observed.
For any missing item-specific details (e.g., solubility limits, solution stability), consult the lot-specific CoA/Spec Sheet and the SDS.
Structure and Identity
Concise overview of identity and core structural class for Sulfacytine.
Item-specific identifiers (from Product Data):
SKU: S649462
Product Name: Sulfacytine
CAS: 17784-12-2
PubChem CID: 5322
Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
SMILES: Not specified for this item; refer to CoA/Spec Sheet.
InChIKey: Not specified for this item; refer to CoA/Spec Sheet.
Structural features (literature/general):
Sulfacytine belongs to the classical aryl sulfonamide family of small molecules. Members of this class typically feature a benzenesulfonamide core (–SO2–NH–) substituted with an anilide/aniline-type nitrogen and a heteroatom-bearing side chain.
Functional group highlights generally include: a primary/secondary sulfonamide (acidic NH), one or more aniline/arylamide nitrogens (basic/weakly basic character), and hydrogen-bond donor/acceptor sites that influence solubility and solid-state packing.
2D structure description (generic for this class): an aromatic ring bearing a sulfonyl group (SO2) attached to an amide-like nitrogen; the second sulfonyl oxygen is terminal; additional substituents on the aryl ring modulate polarity and pKa.
Stereochemistry: No stereocenters are expected for typical aryl sulfonamide scaffolds unless additional chiral substituents are present (literature/general).
Synthetic Utility
Sulfacytine is primarily a defined small molecule rather than a generic building block; nevertheless, aryl sulfonamides can participate in useful transformations in a research setting.
Functional group reactivity (literature/general):
Sulfonamide N–H can undergo deprotonation (strong base) enabling N-alkylation or acylation to give N-substituted derivatives. Protecting-group strategies may exploit the sulfonamide as a directing/protecting element.
The aromatic ring (when present and unsubstituted at relevant positions) may engage in electrophilic aromatic substitution under appropriate conditions; however, the sulfonyl group is deactivating and meta-directing.
Derivatization uses:
Probe development: installation of reporter tags (fluorophores, biotin) via N-alkylation/acylation for target engagement studies.
Prodrug or permeability studies: transient modification of the sulfonamide to modulate lipophilicity and permeability in cell-based assays (non-clinical research only).
Analytical derivatization:
For GC-based workflows, silylation or acylation of polar sites may be used to reduce tailing and improve volatility (method-development context).
Because Sulfacytine is a specific structure, consult its exact substitution pattern (CoA/spec or primary literature) to choose compatible transformations and avoid undesired side reactions.
Target Specificity
This product is a small-molecule reagent, not an antibody or protein. No clone/isotype or species-reactivity information applies.
Item-specific data: Not applicable.
Literature/general context:
In biochemical studies, sulfonamides classically interact with bacterial dihydropteroate synthase (DHPS). Any target information for Sulfacytine should be verified from primary sources for your system of interest.
Refer to assay-specific literature to define molecular targets and binding parameters relevant to your application.
자주 묻는 질문
What is the purity of this product?
This product is supplied at ≥99% purity (chemical assay). Lot-specific values are stated on the Certificate of Analysis.
How should this product be stored?
Store at ?20 °C. Freezer storage is required to maintain the specified shelf life.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 17784-12-2, the molecular formula is C12H14N4O3S, and the molecular weight is 294.33 g/mol.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.